<DOC>
	<DOCNO>NCT02915510</DOCNO>
	<brief_summary>This study evaluate safety , gastrointestinal ( GI ) tolerance , acceptability compliance Glycomacropeptide-based protein substitute patient Phenylketonuria ( PKU ) .</brief_summary>
	<brief_title>GMP Drink PKU Study</brief_title>
	<detailed_description />
	<mesh_term>Phenylketonurias</mesh_term>
	<criteria>Male female Over 3 year age Diagnosed classical variant type phenylketonuria Have compliant take least one amino acidbased , Phefree protein substitute , provide least 20g protein equivalent , least 1 month prior trial commencement Have prescribe daily Phe allowance Written inform consent patient , parent / carer applicable Currently prescribe Sapropterin similar tetrahydrobiopterin base medication Pregnant lactate Requiring parenteral nutrition Major hepatic renal dysfunction Participation study within 1 month prior entry study Allergy study product ingredient , include milk protein soya Investigator concern around willingness/ability patient parent/carer comply protocol requirement</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>